TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

COVID-19 Antibody testing on the Liasion XL platform in Microbiology Lab (UHW)

Chemical reagents
Laboratory reagents
Wales (UKL)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Wales Shared Services Partnership: "COVID-19 Antibody testing on the Liasion XL platform in Microbiology Lab (UHW)". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS Wales Shared Services PartnershipScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS Wales Shared Services Partnership
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS Wales Shared Services Partnership. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
3.1Bids / Report
40% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 36 active published awards; 35 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS Wales Shared Services Partnership
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published8 Mar 2021, 11:08 GMT
Last source update8 Mar 2021, 11:08 GMT
Recurring procurementNot published
ClassificationChemical reagents, Laboratory reagents
Delivery area
Wales (UKL)
OCIDocds-h6vhtk-029946
What is being bought
COVID-19 Antibody testing on the Liasion XL platform in Microbiology Lab (UHW)
What changed
From the official release history
  1. Status changed to complete
    8 Mar 2021, 11:08 GMT
  2. Official notice release published
    8 Mar 2021, 11:08 GMT
  3. Buyer information updated
    8 Mar 2021, 11:08 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    NHS Wales Shared Service Partnership on behalf of Public Health Wales NHS Trust wish to inform the market that due to the Covid-19 global pandemic they are awarding a contract for the provision of testing kits, equipment, reagents and any other associated consumables required to operate the testing platforms. The UK government has mandated UK Health Boards and Trusts to carry out antibody and antigen testing for the wider population as well as those working in Healthcare and Care settings. Therefore in order to enable the provision of these testing kits, equipment, reagent and other associated consumables required to operate the testing platforms, Public Health Wales would like to inform the market that under Regulation 32 (2) (C) of the Public Contracts Regulations 2015 (PCR’s) as detailed in UK Government guidance PPN 01/20 they are awarding a contract to Diasorin. The Trust has met all the tests for awarding a contract under this regulation due to the immediate risk that COVID-19 poses to the population of Wales. Additional information: N/A
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    8 Mar 2021, 11:08 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 27 May 2020, 00:00 BST · £172,000
Commercial outcome and competition
Awards
DIASORIN LTD
Not published · Not published · active
Contracts
Contract
£172,000 · signed 27 May 2020, 00:00 BST · active
Bid statistics
bids: 1 (lot 1)
electronicBids: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
smeBids: 0 (lot 1)
Buyer and organisations in this procedure

NHS Wales Shared Services Partnership

Contracting authority GB-FTS-7249
View buyer profile

  • NHS Wales Shared Services Partnership
    buyer
    centralPurchasingBody

    4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw, Cardiff, UK, CF15 7QZ
    shannon.mason@wales.nhs.uk
    +44 1443848585

  • DIASORIN LTD
    supplier

    DIASORIN LTD, Central Road, DARTFORD, UK, DA15LR

  • High Court
    reviewBody

    Royal Courts of Justice, The Strand, London, WC2A 2LL
    +44 2079477501
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleCoronavirus Disease (COVID-19) is an infection disease caused by a newly discovered Coronavirus.